A Global Bioprocess Containers Market Size Study & Forecast, by Type (2D and 3D Bags

The Global Bioprocess Containers Market, valued at approximately USD 6.02 billion in 2024, is poised to experience exponential growth at a remarkable CAGR of 26.3% during the forecast period 2025-2035, reaching an impressive USD 78.53 billion by 2035. Bioprocess containers, particularly in the form of single-use systems, have become indispensable in modern biopharmaceutical manufacturing, serving as the backbone for fluid handling, storage, and transportation of media, buffers, and drug substances. They are engineered to meet the stringent sterility, scalability, and flexibility requirements of advanced therapeutic production, enabling faster batch changeovers and reducing contamination risks. The surging demand for biologics, biosimilars, and personalized medicines, coupled with the shift toward flexible manufacturing strategies, has driven significant adoption of these solutions. Additionally, the rise of cell and gene therapies, with their complex production needs, continues to propel demand for highly specialized container systems that integrate seamlessly into closed, automated workflows.

As the biopharmaceutical landscape expands, industry players are increasingly adopting bioprocess containers to replace traditional stainless-steel equipment, thereby minimizing cleaning validation costs and accelerating time-to-market. The market is further buoyed by advancements in film technology, container design, and modular manufacturing setups, which enable optimized performance and scalability. According to BioPlan Associates, the global single-use bioprocessing market has been witnessing double-digit growth, with the majority of CMOs and large-scale biomanufacturers integrating multi-format disposable solutions into their facilities. Furthermore, growing regulatory support for single-use technologies, combined with increasing investment in R&D for bioprocess innovation, is fostering lucrative opportunities for market participants. However, challenges such as supply chain constraints for medical-grade polymers and concerns over plastic waste management remain areas requiring strategic mitigation.

Regionally, North America dominated the market in 2025, supported by its strong network of biopharmaceutical manufacturers, advanced R&D capabilities, and early adoption of innovative bioprocessing technologies. The United States, in particular, has emerged as a hub for biologics and advanced therapies, with substantial investments in cell culture capacity and GMP facilities. Europe follows closely, driven by strategic collaborations between biotech firms and CMOs, alongside supportive regulatory frameworks in countries like Germany, Switzerland, and the UK. The Asia Pacific region is expected to witness the fastest growth over the forecast period, propelled by rapid expansion of the pharmaceutical sector in China, India, and South Korea. Government incentives, infrastructure development in biotech parks, and a rising number of contract manufacturing facilities are accelerating adoption rates in the region. Meanwhile, Latin America and the Middle East & Africa, though currently smaller markets, are demonstrating promising growth trajectories as biopharma investments and clinical trial activities gain momentum.

Major market player included in this report are:
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Saint-Gobain Performance Plastics
• Corning Incorporated
• Lonza Group AG
• GE Healthcare (Cytiva)
• Meissner Filtration Products, Inc.
• Avantor, Inc.
• Pall Corporation
• Fenner PLC
• Fluence Automation, LLC
• ESI Technologies Group
• FlexBiosys Inc.

Global Bioprocess Containers Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Type:
• 2D and 3D Bags
• Accessories

By Application:
• Process Development
• Upstream Process
• Downstream Process

By End User:
• Pharma & Biopharma Companies
• CMOs & CROs
• Academic & Research Institute

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more